No article text was recorded for this version.
pharmacological treatment gap
Version 1 of 171 papers90 conceptsfrozen 2026-10-04
Papers in this version
- Blog: Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) for the management of nonalcoholic fatty liver disease (NAFLD): A systematic review
- Blog: Mastiha (<i>Pistacia lentiscus</i>) Improves Gut Microbiota Diversity, Hepatic Steatosis, and Disease Activity in a Biopsy‐Confirmed Mouse Model of Advanced Non‐Alcoholic Steatohepatitis and Fibrosis
- Blog: Effectiveness and safety analysis of Danggui Shaoyao Powder for the treatment of non-alcoholic fatty liver disease: study protocol for a randomized, double-blind, placebo-controlled clinical trial
- Blog: Acetyl-11-keto-β-boswellic acid alleviates hepatic metabolic dysfunction by inhibiting MGLL activity
- Blog: Therapeutic Role of Polyphenol Extract from Prunus cerasifera Ehrhart on Non-Alcoholic Fatty Liver
- Blog: Jiao Tai Wan Attenuates Hepatic Lipid Accumulation in Type 2 Diabetes Mellitus
- Blog: Therapeutic potential of TMSC-Exo for non-alcoholic fatty liver disease using the liver-on-a-chip model
- Blog: Gestational Hypoxia and Programing of Lung Metabolism
- Blog: Kaempferol-3-O-Glucuronide Ameliorates Non-Alcoholic Steatohepatitis in High-Cholesterol-Diet-Induced Larval Zebrafish and HepG2 Cell Models via Regulating Oxidation Stress
- Blog: Identification of Novel Therapeutic Targets for MAFLD Based on Bioinformatics Analysis Combined with Mendelian Randomization
- Blog: Pluripotent Stem Cell-Derived Hepatocytes Phenotypic Screening Reveals Small Molecules Targeting the CDK2/4-C/EBPα/DGAT2 Pathway Preventing ER-Stress Induced Lipid Accumulation
- Blog: What are the risk factors and settings for non‐alcoholic fatty liver disease in Asia–Pacific?
- Blog: Matrine improves 17α‐ethinyl estradiol‐induced acute cholestasis in rats
- Blog: Metabolite genetic characterization and bile acid metabolomics reveal deoxycholic acid protective effects on acute pancreatitis
- Blog: Alnustone Ameliorates Metabolic Dysfunction‐Associated Steatotic Liver Disease by Facilitating Mitochondrial Fatty Acid β‐Oxidation via Targeting Calmodulin
- Blog: Genetic association of serum calcium, phosphate, vitamin D, parathyroid hormone, and FGF23 with the risk of aortic stenosis
- Blog: High wall shear stress-dependent podosome formation in a novel murine model of intracranial aneurysm
- Blog: Polyphenolic Composition, Mineral Profile, and Biological Activities in Different Organs of Alpine Woundwort—Insights into Antioxidant and Enzyme Inhibitory Potential
- Blog: Effect of resveratrol on non‑alcoholic fatty liver disease
- Blog: Lactobacillus johnsonii Attenuates Liver Steatosis and Bile Acid Dysregulation in Parenteral Nutrition-Fed Rats
- Blog: Magnolol Alleviates Inflammatory Responses and Lipid Accumulation by AMP-Activated Protein Kinase-Dependent Peroxisome Proliferator-Activated Receptor α Activation
- Blog: Nootkatone, a Sesquiterpene Ketone From Alpiniae oxyphyllae Fructus, Ameliorates Metabolic-Associated Fatty Liver by Regulating AMPK and MAPK Signaling
- Blog: Decitabine facilitates thrombopoiesis independent of the thrombopoietin receptor in zebrafish
- Blog: Protective Effects of Polysaccharides From <i>Sargassum hemiphyllum</i> (Turner) C. Agardh Against Alcohol‐Induced <scp>LO2</scp> Cell Damage
- Blog: Understanding the Role of Exercise and Probiotic Interventions on Non-Alcoholic Fatty Liver Disease Alleviation in Zebrafish: Dialogue Between the Gut and Liver
- Blog: A Neural Hybrid-System Model of the Basal Ganglia
- Blog: Berberine Prevents Disease Progression of Nonalcoholic Steatohepatitis through Modulating Multiple Pathways
- Blog: Dairy product consumption was associated with a lower likelihood of non-alcoholic fatty liver disease: A systematic review and meta-analysis
- Blog: Protective Role of Ginsenoside F1-Enriched Extract (SGB121) in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)
- Blog: Combining Use of Captopril and Losartan Attenuates the Progress of Streptococcus pneumoniae-Induced Tympanosclerosis through the Suppression of TGF-β1 Expression
- Blog: Activation of Pancreatic Acinar FXR Protects against Pancreatitis via Osgin1-Mediated Restoration of Efficient Autophagy
- Blog: Beneficial effects of silibinin on serum lipids, bile acids, and gut microbiota in methionine-choline-deficient diet-induced mice
- Blog: Effectiveness and safety of ultrasound-guided percutaneous microwave ablation for hepatic alveolar echinococcosis
- Blog: Lysosomal-associated protein transmembrane 5 ameliorates non-alcoholic steatohepatitis through degradating CDC42
- Blog: Analyzing MASLD interventional clinical trial registration based on the ClinicalTrials.gov database
- Blog: Age-related hearing loss and its potential drug candidates: a systematic review
- Blog: Bone Marrow Derived-Mesenchymal Stem Cell Improves Diabetes-Associated Fatty Liver via Mitochondria Transformation in Mice
- Blog: Interleukin-17 Weakens the NAFLD/NASH Process by Facilitating Intestinal Barrier Restoration Depending on the Gut Microbiota
- Blog: Oleuropein-Rich Jasminum Grandiflorum Flower Extract Regulates the LKB1-PGC-1α Axis Related to the Attenuation of Hepatocellular Lipid Dysmetabolism
- Blog: Exploring the gut microbiota’s crucial role in acute pancreatitis and the novel therapeutic potential of derived extracellular vesicles
- Blog: Probiotics and Non-Alcoholic Fatty Liver Disease: Unveiling the Mechanisms of Lactobacillus plantarum and Bifidobacterium bifidum in Modulating Lipid Metabolism, Inflammation, and Intestinal Barrier Integrity
- Blog: Dietary intervention reverses molecular markers of hepatocellular senescence in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH
- Blog: Body Mass Index mediates the associations between dietary approaches to stop hypertension and obstructive sleep apnea among U.S. adults
- Blog: An ATF3 Inducer Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease Through the AMPK and PKA Pathways
- Blog: Effects of Fish Oil, Lipid Mediators, Derived from Docosahexaenoic Acid, and Their Co-Treatment against Lipid Metabolism Dysfunction and Inflammation in HFD Mice and HepG2 Cells
- Blog: Sodium-Glucose Transport Protein-2 Inhibitors in the Treatment of Non-alcoholic Steatohepatitis: An Evidence-Based Review
- Blog: Comparative efficacy of pharmacological agents on abdominal aortic aneurysm growth rate: a systematic review and network meta-analysis
- Blog: Omic studies reveal the pathogenic lipid droplet proteins in non-alcoholic fatty liver disease
- Blog: Formononetin Improves the Survival of Random Skin Flaps Through PI3K/Akt-Mediated Nrf2 Antioxidant Defense System
- Blog: Persistent level 1 hypoglycemia due to hypothyroidism and underlying Neurofibromatosis type 1
- Blog: Licorice extract inhibits the cGAS-STING pathway and protects against non-alcoholic steatohepatitis
- Blog: A transcriptomic and proteomic atlas of obesity and type 2 diabetes in cynomolgus monkeys
- Blog: Pachymic acid alleviates metabolic dysfunction-associated steatotic liver disease by inhibiting ferroptosis through PPARα
- Blog: Component compatibility of Yinchenhao decoction attenuates high-fat diet-induced metabolic-associated steatotic liver disease in mice
- Blog: Predictive role of cardiac valvular calcification in all-cause mortality of Chinese initial haemodialysis patients: a follow-up study of 4 years
- Blog: Methane-Rich Saline Counteracts Cholestasis-Induced Liver Damage via Regulating the TLR4/NF-<i>κ</i>B/NLRP3 Inflammasome Pathway
- Blog: Effects of Naltrexone on Expression of Lipid Metabolism‐Related Proteins in Liver Steatosis Induced by Endoplasmic Reticulum Stress in Mice
- Blog: Treatment of rats with Jiangzhi Capsule improves liquid fructose-induced fatty liver: modulation of hepatic expression of SREBP-1c and DGAT-2
- Blog: Anti‐inflammatory actions of acetate, propionate, and butyrate in fetal mouse jejunum cultures ex vivo and immature small intestinal cells in vitro
- Blog: Gan-jiang-ling-zhu decoction improves steatohepatitis by regulating gut microbiota-mediated 12-tridecenoic acid inhibition
Showing 60 of 71 papers.
History & citation
Current · Permanent link
- Pharmacological Interventions for Diseases Lacking Approved Therapies merged into this direction (75% overlap)
Cite this direction
Latest version (a living page):
@misc{lacuna_pharmacological_treatment_gap_9e16553e,
title = {pharmacological treatment gap},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/pharmacological-treatment-gap/rdr_9e16553e94e34264a6f8838ec9d03f80},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-20},
}This exact version (version 1, frozen text):
@misc{lacuna_pharmacological_treatment_gap_9e16553e_v1,
title = {pharmacological treatment gap},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/pharmacological-treatment-gap/rdr_9e16553e94e34264a6f8838ec9d03f80/v/1},
note = {Version 1, frozen 2026-10-04. Accessed 2026-11-20},
}